Researchers Submit Patent Application, "Tools And Instruments For Use With Implantable Encapsulation Devices", for Approval (USPTO 20240245481).

A patent application has been submitted by ViaCyte Inc. for a cellular therapy and means and methods for holding, transferring, sizing, marking, and deploying a cell encapsulation implantable device for the treatment of diabetes mellitus. The invention aims to provide a renewable cell source and an encapsulation source that provides protection against host immunity, minimizing the need for long-term immune-suppressive drugs. The patent application describes a case for holding an implantable device, which includes a detachably connected cover body and base body with openings to allow the passage of biologically active materials. The inventors also provide various embodiments and claims related to the case design and materials used. [Extracted from the article]